This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
HISADA Y. Dysregulated hemostasis in acute promyelocytic leukemia. Int J Hematol. 2024;119[5]:526–31Search in Google Scholar
ÖSTERROOS A., MAIA T., ERIKSSON A., JÄDERSTEN M., LAZAREVIC V., WENNSTRÖM L., et al. A risk score based on real-world data to predict early death in acute promyelocytic leukemia. Haematologica. 2022;107[7]:1528–37.Search in Google Scholar
FONTES HMF., DE FREITAS JP., OLIVEIRA JHV., DE SOUSA MORAES ÉA., REGO EM., MELO RAM. Causes and risk factors for early death in adult patients with acute promyelocytic leukemia: a real-life experience. Hematol Transfus Cell Ther. 2024.Search in Google Scholar
CAI P., WU Q., WANG Y., YANG X., ZHANG X., CHEN S. An effective early death scoring system for predicting early death risk in de novo acute promyelocytic leukemia. Leuk Lymphoma. 2020;61(8):1989–95.Search in Google Scholar
GILL H., YUNG Y., CHU HT., AU WY., YIP PK., LEE E., et al. Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study. Blood Adv. 2021;5(14):2829–38.Search in Google Scholar
GILL H., RAGHUPATHY R., LEE CYY., YUNG Y., CHU HT., NI MY., et al. Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021. BMC Cancer. 2023;23(1):141.Search in Google Scholar
